R176502, a New Bafilolide Metabolite with Potent Antiproliferative Activity from a Novel Micromonospora Species

Laakso, J.A.; Mocek, U.M.; Dun, J.V.; Wouters, W.; Janicot, M.

The Journal of Antibiotics 56(11): 909-916

2003


DOI: 10.7164/antibiotics.56.909
Accession: 068517062

Download citation:  
Text
  |  
BibTeX
  |  
RIS

Article/Abstract emailed within 0-6 h
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal

Abstract
During the course of a screening program intended to identify new antiproliferative agents, a new bafilolide metabolite was discovered. R176502 (1) was isolated from the liquid fermentation cultures of a novel Micromonospora species found in African river bottom sediment. It was purified from ethyl acetate extracts using a series of countercurrent chromatographic steps. The structure was determined using 1- and 2-D NMR experiments. Three previously described bafilomycins (bafilomycins A1 (2), B1 (3), and B2 (4)) were also isolated (from other microbial strains). R176502 exhibited potency for inhibition of tumor cell proliferation in the nM range of concentrations.